NCT06454981 - Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

November 2, 2021

Study Completion Date

February 12, 2022

Conditions

Renal Failure Chronic

Interventions

DEVICE

Hemodiafilter

"The enrolled patients were randomly divided into the experimental group and the control group, using the hemodiafilter (experimental device) produced by Shinva Medical Instrument Co.,Ltd."

DEVICE

Fresenius Medical Care AG & Co.KGaA

The enrolled patients were randomly divided into the experimental group and the control group, using the FX 800HDF hollow fiber hemodialysis/filter (control device) produced by Fresenius Medical Care AG \& Co.KGaA (registered agent: Fresenius Medical Care (shanghai) Company Limted).

Trial Locations (1)

310000

Shulan (Hangzhou) Hospital, Hangzhou

All Listed Sponsors

lead

Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd

OTHER